For a complete listing of events at Reedsburg Public Library, visit the library’s calendar at reedsburg.librarycalendar.com.

TAMPA, FL / ACCESS Newswire / June 6, 2025 / The Mosaic Company (NYSE:MOS) today announced it revised its second quarter and 2025 outlook. Phosphate and Potash Pricing Outlook Phosphate price ...

Mosaic raises DAP price outlook but cuts phosphate production forecast for Q2 and full year. Operational delays at key U.S. facilities impact output; recovery expected by third quarter. 3 Summer ...

TAMPA, FL / ACCESS Newswire / June 6, 2025 / The Mosaic Company (NYSE:MOS) today announced it revised its second quarter and 2025 outlook. Phosphate price guidance moves higher: DAP prices on an ...

A 1,600-year-old Byzantine-era mosaic from a Christian monastery was recently put on public display for the first time, giving a glimpse into life during ancient times. The Israeli Ministry of ...

Mosaic is excited to officially share the launch of Trailside, selling 10 homes in the first 48 hours of sales VANCOUVER, British Columbia, May 08, 2025 (GLOBE NEWSWIRE) — Mosaic Homes (Mosaic) is ...

Mosaic Youth Theatre of Detroit is bringing Shakespeare’s “Julius Caesar” to the D — quite literally. The theatre is reimagining the classic play in modern times, set in a Detroit high ...

TAMPA, FL / ACCESS Newswire / May 6, 2025 / The Mosaic Company (NYSE:MOS) released its financial results for the first quarter of 2025. The company's earnings release and supplemental materials ...

Mosaic Therapeutics a UK-based oncology company has announced it has in-licensed two clinical-stage oncology programmes from Astex Pharmaceuticals. The agreement transforms Mosaic from a ...

Mosaic Therapeutics has secured the latest pieces in its combination medicine strategy by licensing two clinical stage tumor drugs from fellow British biotech Astex Pharmaceuticals. The small ...

In-licensing these clinical-stage assets has significantly de-risked and accelerated Mosaic’s development path; the compounds will be developed as proprietary combination therapies Syncona Ltd, ...